Description
BPC-157 | Synthetic Pentadecapeptide – Research Peptide
BPC-157 is a synthetic 15-amino-acid sequence derived from a protective protein found in human gastric juice. It is notable among research peptides for its stability in aqueous solution.
Preclinical studies have examined its influence on growth factor receptor expression, angiogenic signaling through the VEGFR2, Akt and eNOS pathway, and fibroblast migration in cell-culture models.
Common research applications: angiogenesis signaling assays, growth-factor receptor expression studies, and fibroblast migration studies.
Specifications
| Compound | BPC-157 |
|---|---|
| Quantity | 10mg per vial |
| Purity | 99%+ (HPLC/MS) |
| Form | Lyophilized powder |
| Storage | Store lyophilized at minus 20 C, protect from light. |
📚 Research guide: Read our What Is BPC-157? A Research Overview
Compared in our research guides: BPC-157 vs TB-500
Also available as a blend: this compound is one of four components in KLOW Blend 80mg — see the KLOW research guide.
Other BPC-157 sizes: 5mg
Frequently Asked Questions
What is BPC-157?
BPC-157 is a synthetic 15-amino-acid sequence derived from a protective protein found in human gastric juice, notable for aqueous stability.
What is BPC-157 studied for?
Research applications include angiogenic signaling through the VEGFR2, Akt and eNOS pathway, growth factor receptor expression and fibroblast migration. All work is laboratory research only.
What purity is BPC-157 10mg supplied at?
It is supplied as lyophilized powder at 99%+ purity, verified by independent HPLC and mass spectrometry testing.
Is BPC-157 available in other sizes?
Yes. BPC-157 is also available as BPC-157 5mg.
For Research Use Only
This material is intended strictly for laboratory and research purposes. It is not intended for human or veterinary use, diagnosis, treatment, or consumption. By purchasing, the buyer confirms they are a qualified researcher and agrees to handle this product in compliance with all applicable regulations.
Reviews
There are no reviews yet.